CLS Holdings USA, Inc.
CLS Holdings USA, Inc. (CLSH.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
clsh.cn · pe ratio · data through May 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CLS Holdings USA, Inc. (CLSH.CN) measures how much investors pay for each dollar of the company's trailing earnings. CLSH.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of -$0.05.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-05-31
PE Ratio History
2013 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CLS Holdings USA, Inc.You CLSH.CN | $8M | N/A | — | -$0.05 |
 Avant Brands Inc. AVNT.TO | $7M | N/A | — | -$0.88 |
 Ayurcann Holdings Corp. AYUR.CN | $2M | N/A | — | -$0.02 |
 Blueberries Medical Corp. BBM.CN | $5M | N/A | — | -$0.00 |
 Christina Lake Cannabis Corp. CLC.CN | $7M | 7.30x | — | $0.00 |
 Crescita Therapeutics Inc. CTX.TO | $15M | N/A | — | -$0.00 |
 Delivra Health Brands Inc. DHB.V | $4M | N/A | — | -$0.04 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-05-31Latest FY2024 | — | $-0.05 | — | |
2023-05-31 FY2023 | — | $-0.23 | — | |
2022-05-31 FY2022 | — | $-0.07 | — | |
2021-05-31 FY2021 | — | $-0.52 | — | |
2020-05-31 FY2020 | — | $-0.97 | — | |
2019-05-31 FY2019 | — | $-1.08 | — | |
2018-05-31 FY2018 | — | $-0.98 | — | |
2017-05-31 FY2017 | — | $-0.94 | — | |
2016-05-31 FY2016 | — | $-0.52 | — | |
2015-05-31 FY2015 | — | $-0.35 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CLS Holdings USA, Inc. (CLSH.CN) measures how much investors pay for each dollar of the company's trailing earnings. CLSH.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.04 by its TTM earnings per share of -$0.05.
Frequently asked questions
CLSH.CN pe ratio · 6 questionsCLSH.CN's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.04 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via CLSH.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CLS Holdings USA, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08